New AI Blood Test Could Change Cancer Screening for Thousands

Following recent efforts to speed up medical diagnoses across the UK, a new AI-powered blood test is set to change how the NHS investigates potential cancer cases. This new development, which focuses on identifying cancer risks through blood analysis, aims to spare thousands of women from undergoing painful and intrusive examinations every year. This follows yesterday’s news regarding new rapid tests for endometriosis, showing a broader trend of using modern technology to improve women’s healthcare.

According to The Guardian Health, around 90,000 postmenopausal women in England are referred by their doctors each year because of heavy bleeding, which can be a sign of womb cancer. Under the current system, these women must undergo a transvaginal ultrasound scan—a procedure where a device is placed inside the body to check the lining of the womb. While this is a standard part of the diagnostic process, many patients find the experience uncomfortable or painful. The new PinPoint blood test offers a way to safely identify who actually needs these scans and who does not.

Developed by a Leeds-based company, the PinPoint test uses machine learning—a type of computer technology that learns patterns from data—to analyze 30 different markers in a patient's blood. By looking at these markers, the system can determine if a person is at low, elevated, or high risk of having cancer. The Guardian Health reports that in a trial involving over 16,000 patients, the test showed a 99% accuracy rate in detecting gynaecological cancers and, just as importantly, in ruling out the presence of the disease.

For many patients, this technology could provide a much faster and less stressful experience. Dr. Jacinta Walsh, a GP in West Yorkshire, noted that it currently often takes up to six visits to a doctor before they can officially rule out cancer. She explained that the new test will help shorten this process, giving patients peace of mind much earlier while also freeing up time for doctors to see other patients who need urgent care. By identifying low-risk cases quickly, the NHS can focus its resources on those who truly require further investigation.

Medical professionals have welcomed the news. Prof. Sean Duffy, the chief medical officer for the company behind the test, described the 99% accuracy rate as remarkable by any clinical standard. He emphasized that the true value of the test lies in its ability to safely identify women who are at very low risk, allowing them to avoid invasive procedures that they do not actually need. Brent Kilmurray, the chief executive of the Mid Yorkshire NHS trust, added that there is an especially compelling case for hospitals to adopt this technology, particularly for detecting gynaecological cancers.

Despite the excitement, experts remain aware of the challenges that come with current diagnostic methods. Tracy Jackson, a consultant gynaecologist at the Leeds trust, explained that doctors are very aware that current investigations can be uncomfortable. She noted that because most women referred for these checks do not actually have cancer, finding a way to reduce unnecessary testing is a top priority. The PinPoint test represents a significant step toward that goal, as it could save one in five referred women—about 18,000 people a year—from needing a transvaginal scan.

As the NHS begins to introduce this technology in hospitals across Yorkshire, many are watching to see how it will affect patient outcomes on a larger scale. The shift toward AI-assisted diagnostics is part of a wider move to modernize the health service. By using statistical analysis of medical data, the NHS hopes to move away from a 'one-size-fits-all' approach to cancer screening. If the rollout proves successful in these initial hospitals, it is likely that the use of such AI tools will expand, potentially changing the standard of care for many other types of cancer in the future. For now, the focus remains on ensuring that patients receive the right care at the right time, without the need for unnecessary pain.